Amid heightened public concern, the cost of prescription drugs is the focus of renewed attention by the Trump administration, the Biden campaign and lawmakers in Congress and state capitals. Proposed actions range from sweeping health care system changes to targeted initiatives that could affect Medicare, Medicaid and private insurance. See KFF’s research, analysis and public opinion data, as well as Kaiser Health News’ journalism, related to prescription drugs and their costs.
Featured Prescription Drugs Resources

KFF Health Tracking Poll – October 2019: Health Care In The Democratic Debates, Congress, And The Courts
This poll examines health care issues in the Democratic presidential primary , government negotiation of prescription drug prices, party trust on health care, Medicare-for-all, and the pending Texas v. US lawsuit affecting the Affordable Care Act and pre-existing condition protections.
Poll Finding See More
Related Prescription Drugs Resources
- Assessing Drug Price Increases in Medicare Part D and the Implications of Inflation Limits
- 10 FAQs on Prescription Drug Importation
- Pricing and Payment for Medicaid Prescription Drugs
- Management and Delivery of the Medicaid Pharmacy Benefit
- Understanding the Medicaid Prescription Drug Rebate Program
- A Look at Recent Proposals to Control Drug Spending by Medicare and its Beneficiaries
- Kaiser Health News Coverage of Prescription Drug Issues
- What are the recent and forecasted trends in prescription drug spending?
- What’s the Latest on Medicare Drug Price Negotiations?
- How Will The Medicare Part D Benefit Change Under Current Law and Leading Proposals?
- Medicaid’s Prescription Drug Benefit: Key Facts
- Public Opinion on Prescription Drugs and Their Prices
- Prescription Drug Rebates, Explained
- Who is Most Likely to Have High Prescription Drug Costs?
- Snapshots of Recent State Initiatives in Medicaid Prescription Drug Cost Control
- 10 Essential Facts About Medicare and Prescription Drug Spending
- Utilization and Spending Trends in Medicaid Outpatient Prescription Drugs
- How Does Prescription Drug Spending and Use Compare Across Large Employer Plans, Medicare Part D, and Medicaid?

What’s the Latest on Prescription Drug Proposals from the Trump Administration, Congress, and the Biden Campaign?
This slideshow explains the similarities and differences among major proposals to lower prescription drug costs introduced by the Trump Administration, members of Congress, and the Biden campaign.
Slideshow See More
Refine Results
- view as grid
- view as list
Americans Value the Health Benefits of Prescription Drugs, But Say Drug makers Put Profits First, New Survey Shows – Toplines
The most recent Kaiser Health Poll Report found that Americans believe prescription drugs are improving their lives, but most also say that the drug industry cares more about profits than people. The current report analyzes the new data as well as related polling information from earlier surveys by the Kaiser…
Poll Finding Read MoreSummary of Final Regulations Implementing the New Medicare Prescription Drug Benefit
This document summarizes the final regulations to implement the new Medicare prescription drug benefit. The regulations were published by the Centers for Medicare and Medicaid Services (CMS) as a final rule in the Jan. 28 Federal Register. It provides an overview that allows interested parties to obtain information about specific…
Issue Brief Read MoreTransitions 2005
Transitions is a video that explores some of the issues and challenges “dual eligibles” may face during the transition from Medicaid drug coverage to Medicare. To download the video, right-click here and select “Save as…”
Video Read MoreHealth Care Agenda for the New Congress
This survey captures the public’s attitudes regarding the health care agenda for Bush’s second term and the new Congress in 2005. It assesses the relative priority placed on health-care concerns by the American public and also provides insight into public opinion on key issues likely to face the new Congress,…
Poll Finding Read MoreImplications of the Medicare Modernization Act for States: Observations from a Focus Group Discussion with Medicaid Director – Report
Implications of The Medicare Modernization Act For States: Observations from a Focus Group Discussion with Medicaid DirectorsThis report summarizes a discussion with a group of state Medicaid officials about the impact of the Medicare prescription drug benefit on state Medicaid programs. Report (.pdf)
Report Read MoreThe New Medicare Prescription Drug Law: Issue for Enrolling Dual Eligibles into Drug Plans – Issue Paper
The New Medicare Prescription Drug Law: Issues for Enrolling Dual Eligibles into Drug PlansThis report describes the characteristics of dual eligibles and then discussess four key elements of the transition of their drug coverage to Medicare.Issue Paper (.pdf)
Issue Brief Read MoreMedicare’s New Prescription Drug Benefit: The Voices of People Dually Covered by Medicare and Medicaid – Report
Medicare's New Prescription Drug Benefit: The Voices of People Dually Covered by Medicare and MedicaidThis focus group report highlights the kinds of questions, uncertainties, and reactions that dual eligibles have when asked about the impending changes in their drug coverage.Report (.pdf)
Report Read MoreNew Survey Assesses Senior’s Views of Medicare Drug Law
New Survey Assesses Senior’s Views of Medicare Drug Law Seniors are most likely to say they would turn to their doctor, pharmacist, or the Medicare program, for help in making decisions about the new Medicare drug benefit set to begin Jan. 1, 2006, according to new data from the Kaiser…
Poll Finding Read MoreHealth Care Agenda for the New Congress – Chartpack
This chartpack provides key findings from the survey of the public’s attitudes regarding the health care agenda for Bush’s second term and the new Congress in 2005. It assesses the relative priority placed on health-care concerns by the American public and also provides insight into public opinion on key issues…
Poll Finding Read MoreHealth Care Agenda for the New Congress – Toplines
This document includes the complete toplines from a survey of the public’s attitudes regarding the health care agenda for Bush’s second term and the new Congress in 2005. It assesses the relative priority placed on health-care concerns by the American public and also provides insight into public opinion on key…
Poll Finding Read More